Home › NDC Lookup › RxCUI directory › RxCUI 1665050

Cefazolin 1000 MG Injection — RxCUI 1665050

RxNorm drug concept · Semantic clinical drug
RxCUI 1665050 Semantic clinical drug · SCD ● Current RxNorm concept 31 FDA products 31 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1665050
Official nameCefazolin 1000 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascefazolin 1 GM Injection; cefazolin 1 GM (as cefazolin sodium) Injection
FDA products mapped31
Package NDCs mapped31
Reported Medicaid activity (SDUD)194,761 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefazolin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is an antibiotic for bacterial infections of the lungs, urinary tract, skin, bile ducts, bones and joints, genital tract, blood and heart valves. It is also used to help prevent...
  • A healthcare professional gives it, usually into a vein over about 30 minutes, though some products can be given into a muscle. It is repeated several times a day for infections. B...
  • The more common ones are nausea, vomiting, diarrhea, rash, headache and soreness at the injection site. These are usually mild. Tell your nurse if something bothers you.
  • Get emergency help for trouble breathing, swelling, hives or chest pain. Also tell your team about seizures, severe or watery diarrhea (even weeks later), unusual bleeding, or blis...
📖 Read our full Cefazolin Injection guide →

🕸️ Concept Web — How Cefazolin 1000 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cefazolin 1000 MG Injection RxCUI 1665050

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cefazolin 2180
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cefazolin Injection 1665049
    • Cefazolin Injectable Product 1152094
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cefazolin 1000 MG 1665048

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cefazolin 1000 MG SCDC · 1665048
  • Cefazolin Injection SCDF · 1665049
  • Cefazolin Injectable Product SCDG · 1152094

📦 FDA Products & Package NDCs

31 products · 31 package NDCs
31 package NDCs map to RxCUI 1665050 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9262-25 25 VIAL in 1 CARTON (0143-9262-25) / 3 mL in 1 VIAL (0143-9... Cefazolin Hikma Pharmaceuticals USA Inc. 2001-09-18
00143-9923-90 2.2 mL in 1 VIAL (0143-9923-90) Cefazolin Hikma Pharmaceuticals USA Inc. 2001-09-18
00143-9924-90 3 mL in 1 VIAL (0143-9924-90) Cefazolin Hikma Pharmaceuticals USA Inc. 2001-09-18
00264-3103-11 24 CONTAINER in 1 CASE (0264-3103-11) / 50 mL in 1 CONTAINE... Cefazolin Sodium B. Braun Medical Inc. 2000-07-27
00264-3105-11 24 CONTAINER in 1 CASE (0264-3105-11) / 50 mL in 1 CONTAINE... Cefazolin Sodium B. Braun Medical Inc. 2012-01-13
00264-3107-11 24 CONTAINER in 1 CASE (0264-3107-11) / 50 mL in 1 CONTAINE... Cefazolin Sodium B. Braun Medical Inc. 2025-03-10
00338-0096-06 6 BAG in 1 CARTON (0338-0096-06) / 150 mL in 1 BAG Cefazolin Baxter Healthcare Corporation 2024-05-31
00338-3503-41 24 BAG in 1 CARTON (0338-3503-41) / 50 mL in 1 BAG Cefazolin Baxter Healthcare Corporation 2015-08-07
00338-3508-41 12 BAG in 1 CARTON (0338-3508-41) / 100 mL in 1 BAG Cefazolin Baxter Healthcare Corporation 2015-08-07
00404-9833-99 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9833-99) / 1 INJECTION,... CEFAZOLIN Henry Schein, Inc. 2022-01-09
00404-9834-99 1 VIAL in 1 BAG (0404-9834-99) / 3 mL in 1 VIAL CEFAZOLIN Henry Schein, Inc. 2022-01-09
00409-2585-01 25 VIAL in 1 CARTON (0409-2585-01) / 1 INJECTION, POWDER, F... Cefazolin Hospira, Inc 2007-08-07
00781-3451-95 10 VIAL in 1 CARTON (0781-3451-95) / 1 INJECTION, POWDER, F... Cefazolin Sandoz Inc 2026-01-05
00781-3451-96 25 VIAL in 1 CARTON (0781-3451-96) / 1 INJECTION, POWDER, F... Cefazolin Sandoz Inc 1988-12-09
44567-0120-25 25 VIAL in 1 CARTON (44567-120-25) / 1 INJECTION, POWDER, F... Cefazolin WG Critical Care, LLC 2019-04-23
44567-0706-25 25 VIAL in 1 CARTON (44567-706-25) / 1 INJECTION, POWDER, F... Cefazolin WG Critical Care, LLC 2015-03-06
44567-0707-25 25 VIAL in 1 CARTON (44567-707-25) / 1 INJECTION, POWDER, F... Cefazolin WG Critical Care, LLC 2015-03-06
50090-4256-00 25 VIAL in 1 BOX (50090-4256-0) / 3 mL in 1 VIAL Cefazolin A-S Medication Solutions 2019-04-05
60505-6142-05 25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6142-5) / 1 INJECTI... Cefazolin Apotex Corp. 2017-06-30
60505-6231-05 25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6231-5) / 1 INJECTI... Cefazolin Apotex Corp. 2022-03-18
60505-6243-04 25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6243-4) / 1 INJECTI... Cefazolin Apotex Corp. 2022-09-01
60505-6266-05 25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6266-5) / 1 INJECTI... Cefazolin Apotex Corp. 2024-02-13
63323-0236-10 25 VIAL in 1 CARTON (63323-236-10) / 2.2 mL in 1 VIAL (6332... CEFAZOLIN Fresenius Kabi USA, LLC 2011-07-15
63323-0237-10 25 VIAL in 1 CARTON (63323-237-10) / 3 mL in 1 VIAL (63323-... CEFAZOLIN Fresenius Kabi USA, LLC 2011-07-15
67184-1001-02 25 VIAL in 1 CARTON (67184-1001-2) / 1 INJECTION, POWDER, F... Cefazolin Qilu Pharmaceutical Co., Ltd. 2015-12-28
71205-0679-01 1 VIAL, SINGLE-DOSE in 1 BOX (71205-679-01) / 1 INJECTION,... Cefazolin Proficient Rx LP 2022-08-01
71872-7027-01 1 VIAL in 1 BAG (71872-7027-1) / 3 mL in 1 VIAL Cefazolin Medical Purchasing Solutions, LLC 2018-02-28
71872-7141-01 1 VIAL, SINGLE-DOSE in 1 BAG (71872-7141-1) / 1 INJECTION,... Cefazolin Medical Purchasing Solutions, LLC 2018-07-13
72189-0584-01 1 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (72189-584-01) Cefazolin Sodium Direct_rx 2024-09-24
72572-0055-25 25 VIAL in 1 CARTON (72572-055-25) / 1 INJECTION, POWDER, F... Cefazolin Civica, Inc. 2022-03-01
84549-0142-05 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (84... Cefazolin ProPharma Distribution 2025-09-01
Observed labelers: Apotex Corp. (4) · B. Braun Medical Inc. (3) · Baxter Healthcare Corporation (3) · Hikma Pharmaceuticals USA Inc. (3) · WG Critical Care, LLC (3) · Fresenius Kabi USA, LLC (2) · +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0690 Cefazolin sodium injection 21 CMS
J0689 Inj cefazolin sodium, baxter 3 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.